Drug Profile
ARC 67085
Alternative Names: ARL 67085; FPL 67085Latest Information Update: 22 Jan 2007
Price :
$50
*
At a glance
- Originator AstraZeneca R&D Charnwood
- Class Antithrombotics; Neuroprotectants; Small molecules
- Mechanism of Action Purinergic P1 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Thrombosis
Most Recent Events
- 07 Apr 1999 Merger of Astra and Zeneca to form AstraZeneca completed
- 28 Jan 1999 ARL 67085 is now called ARC 67085
- 12 Sep 1997 FPL 67085 is now called ARL 67085